New findings presented at the 2025 Alzheimer’s Association International Conference (AAIC) in Toronto spotlighted the long-term potential of two FDA-approved Alzheimer’s treatments for people with ...

Differences in outcomes between patients with early Alzheimer’s disease who used lecanemab and matched controls increased ...

As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets.

"Nuvectis Pharma cuts NXP800 in ovarian cancer after early failure" was originally created and published by Clinical Trials ...